Is interesting to note that the 68 MPN patients with concomitantly altered platelet- and RBC phenotype showed the highest median allele burden of their MPN driver mutations hitting JAK2-, CALR- or MPL gene (Table 1), whereas those with none of these morphological alterations had the lowest (Fig. 1C). The gene discussed is JAK2; the disease is myeloproliferative neoplasm.